Citations

Clear

382 citation(s) found for "Shapiro, CL".

Genomic characteristics of deleterious BRCA1 and BRCA2 alterations and associations with baseline clinical factors in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in TRITON2.
Abida, Wassim , Amato, Robert J., Percent, Ivor , Shapiro, Jeremy , McDermott, Raymond S., Hussain, Arif , Petrylak, Daniel P. , Ryan, Charles J. , Stanton, T., Zhang, Jingsong , Loehr, Andrea , Simmons, Andrew D. , Despain, Darrin , Golsorkhi, Anthony A., Watkins, Simon P. , Scher, Howard I. , Chowdhury, Simon, Watkins, Simon P , Bryce, Alan H. , Vogelzang, Nicholas J. , McDermott, Raymond S., Patnaik, Akash

Mayo Clinic

Journal of Clinical Oncology | May 27, 2019 | Volume: 37 | Issue: 15_suppl | Pages: 5031-5031

10.1200/jco.2019.37.15_suppl.5031 Get It

5031 Background: The phase 2 TRITON2 study (NCT02952534) is evaluating the PARP inhibitor rucaparib in patients with mCRPC who have a deleterious germline or somatic alteration in BRCA ( BRCA1 or BRCA2) or 1 of 13 other DNA damage repair genes. Here we present analyses of tumor genomics and baseline clinical characteristics in mCRPC patients with a deleterious alteration in BRCA. Methods: Plasma (baseline) and tissue (archival or baseline) samples from patients with a deleterious alteration in BRCA were analyzed using Foundation Medicine next-generation sequencing assays. The alterations and zygosity of the alterations that were detected, as well as the somatic/germline status from Color Genomics testing, were summarized. Associations between genomic alterations, DNA yield, allele frequency, and baseline clinical characteristics were investigated. Results: Results are shown in the Table for a cohort of 40 BRCA2 and 5 BRCA1 patients enrolled in TRITON2 (Abida W et al. Presented at ESMO 2018. Abst 793PD). A biallelic alteration was observed in 21 of the 22 BRCA2 patients (95%) for whom alteration zygosity could be determined. Among the 5 BRCA1 patients, 1 alteration was monoallelic and 4 were of unknown zygosity. Co-occurring alterations in cancer-related or DNA damage repair genes were observed in many patients with BRCA alterations. At baseline, cell-free DNA (cfDNA) yield correlated positively with the sum of target lesions (STL; P= 0.04), but not with prostate-specific antigen (PSA) levels ( P= 0.86). No correlation was observed between allele frequency of the BRCA alteration baseline STL ( P= 0.68) or PSA levels ( P= 0.97). Conclusions: Patients with a BRCA mutation enrolled in TRITON2 demonstrate a profile of genomic alterations consistent with that of prior studies of patients with mCRPC. Plasma cfDNA profiling showed a correlation between baseline cfDNA yield and measurable tumor burden, but not baseline PSA. Clinical trial information: NCT02952534. [Table: see text]
Diagnostic Dilemmas: Diastolic Heart Failure Causing Pulmonary Hypertension and Pulmonary Hypertension Causing Diastolic Dysfunction
Shapiro, Brian P. , McGoon, Michael D., Redfield, Margaret M. , Nishimura, Rick A.

Mayo Clinic

Advances in Pulmonary Hypertension | May 7, 2019 | Volume: 5 | Issue: 1 | Pages: 13-20

10.21693/1933-088x-5.1.13 Get It

CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer.
Himelstein, Andrew L., Qin, Rui , Novotny, Paul J. , Seisler, Drew K., Khatcheressian, James, Roberts, John D. , Grubbs, Stephen S., Weckstein, Douglas, Loprinzi, Charles L. , O’Connor, Tracey L. , Shapiro, Charles L.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 9501-9501

10.1200/jco.2015.33.15_suppl.9501 Get It

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome
Makhani, Naila , Sıva, Aksel , Narula, Sona , Wassmer, Evangeline , Brassat, David, Brenton, J. Nicholas , Cabre, Philippe, Carra‐Dallière, Clarisse , Dubief, Françoise Durand, Inglese, Matilde , Langille, Megan, Mathey, Guillaume , Pelletier, Jean , Reich, Daniel S. , Rojas, Juan Ignacio , Shabanova, Veronika , Shapiro, Eugene D. , Stone, Robert T, Tenembaum, Sílvia , Tintoré, Mar , Uygunoğlu, Uğur , Vargas, Wendy , Venkateswaren, Sunita, Kantarci, Orhun H. , Pelletier, Daniel , Durand‐Dubief, Françoise , Carra Dallière, Clarisse , Reich, Daniel S , Tintoré, Mar , Brenton, J Nicholas , Siva, Aksel , Lebrun‐Frénay, Christine , Seze, Jerome De , Neuteboom, Rinze Frederik , Pohl, Daniela , Stone, Robert Thompson, Vermersch, Patrick , Okuda, Darin T. , Wassmer, Evangeline , Durand-Dubief, Françoise

Mayo Clinic

Multiple Sclerosis Journal - Experimental, Translational and Clinical | March 21, 2019 | Volume: 5 | Issue: 1 | Pages: No page available

10.1177/2055217319836664 | PMID 30915227 Get It

Background Steps towards the development of diagnostic criteria are needed for children with the radiologically isolated syndrome to identify children at risk of clinical demyelination. Objectives To evaluate the 2005 and 2016 MAGNIMS magnetic resonance imaging criteria for dissemination in space for multiple sclerosis, both alone and with oligoclonal bands in cerebrospinal fluid added, as predictors of a first clinical event consistent with central nervous system demyelination in children with radiologically isolated syndrome. Methods We analysed an international historical cohort of 61 children with radiologically isolated syndrome (≤18 years), defined using the 2010 magnetic resonance imaging dissemination in space criteria (Ped-RIS) who were followed longitudinally (mean 4.2 ± 4.7 years). All index scans also met the 2017 magnetic resonance imaging dissemination in space criteria. Results Diagnostic indices (95% confidence intervals) for the 2005 dissemination in space criteria, with and without oligoclonal bands, were: sensitivity 66.7% (38.4–88.2%) versus 72.7% (49.8–89.3%); specificity 83.3% (58.6–96.4%) versus 53.9% (37.2–69.9%). For the 2016 MAGNIMS dissemination in space criteria diagnostic indices were: sensitivity 76.5% (50.1–93.2%) versus 100% (84.6–100%); specificity 72.7% (49.8–89.3%) versus 25.6% (13.0–42.1%). Conclusions Oligoclonal bands increased the specificity of magnetic resonance imaging criteria in children with Ped-RIS. Clinicians should consider testing cerebrospinal fluid to improve diagnostic certainty. There is rationale to include cerebrospinal fluid analysis for biomarkers including oligoclonal bands in planned prospective studies to develop optimal diagnostic criteria for radiologically isolated syndrome in children.
Faculty Opinions recommendation of Guidelines for the use of flow cytometry and cell sorting in immunological studies.
Lehrke, Michael Jonathan , Shapiro, Virginia Smith

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 14, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.731982221.793557362 Get It

Phase I, first-in-human trial of LV305 in patients with advanced or metastatic cancer expressing NY-ESO-1.
Somaiah, Neeta , Block, Matthew S. , Hwu, Patrick , Jones, Robin L. , Gnjatic, Sacha , Lu, Hailing , Hsu, Frank J., Gnjatic, Sacha , Jones, Robin L , Kim, Joseph W. , Shapiro, Geoffrey I. , Hwu, Patrick , Eder, Joseph P. , Pollack, Seth M.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3021-3021

10.1200/jco.2015.33.15_suppl.3021 Get It

Ask the Expert: Is Cardiac Magnetic Resonance Imaging Underutilized in the Diagnosis of Pulmonary Hypertension?
Studer, Sean , Ray, Jordan , Blackshear, Joseph L., Safford, Robert E. , Mergo, Patricia J. , Shapiro, Brian P. , Burger, Charles D.

Mayo Clinic

Advances in Pulmonary Hypertension | February 26, 2019 | Volume: 14 | Issue: 2 | Pages: 102-104

10.21693/1933-088x-14.2.102 Get It

NKAP Must Associate with HDAC3 to Regulate Hematopoietic Stem Cell Maintenance and Survival
Shapiro, Michael J. , Lehrke, Michael Jonathan , Chung, Ji Young, Arocha, Sinibaldo Romero , Shapiro, Virginia Smith , Shapiro, Michael Jeremy , Romero Arocha, Sinibaldo, Shapiro, Virginia S , Lehrke, Michael J

Mayo Clinic

The Journal of Immunology | February 25, 2019 | Volume: 202 | Issue: 8 | Pages: 2287-2295

10.4049/jimmunol.1800862 | PMID 30804042 Get It

Abstract NKAP is a multifunctional nuclear protein that associates with the histone deacetylase HDAC3. Although both NKAP and HDAC3 are critical for hematopoietic stem cell (HSC) maintenance and survival, it was not known whether these two proteins work together. To assess the importance of their association in vivo, serial truncation and alanine scanning was performed on NKAP to identify the minimal binding site for HDAC3. Mutation of either Y352 or F347 to alanine abrogated the association of NKAP with HDAC3, but did not alter NKAP localization or expression. Using a linked conditional deletion/re-expression system in vivo, we demonstrated that re-expression of the Y352A NKAP mutant failed to restore HSC maintenance and survival in mice when endogenous NKAP expression was eliminated using Mx1-cre and poly-IC, whereas re-expression of wild type NKAP maintained the HSC pool. However, Y352A NKAP did restore proliferation in murine embryonic fibroblasts when endogenous NKAP expression was eliminated using ER-cre and tamoxifen. Therefore, Y352 in NKAP is critical for association with HDAC3 and for HSC maintenance and survival but is not important for proliferation of murine embryonic fibroblasts, demonstrating that NKAP functions in different complexes in different cell types.
Author response: HDAC3 restrains CD8-lineage genes to maintain a bi-potential state in CD4+CD8+ thymocytes for CD4-lineage commitment
Gaonkar, Krutika S. , Chung, Ji Young, Ördög, Tamás , Philips, Rachael L. , Lee, Jeong‐Heon , Chanana, Pritha , Arocha, Sinibaldo Romero , Schwab, Aaron , Shapiro, Virginia Smith

Mayo Clinic

No container title available | January 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.43821.038 Get It

HDAC3 restrains CD8-lineage genes to maintain a bi-potential state in CD4+CD8+ thymocytes for CD4-lineage commitment
Philips, Rachael L. , Lee, Jeong‐Heon , Gaonkar, Krutika S. , Chanana, Pritha , Chung, Ji Young, Arocha, Sinibaldo Romero , Schwab, Aaron , Ördög, Tamás , Shapiro, Virginia Smith , Philips, Rachael Laura, Gaonkar, Krutika, Romero Arocha, Sinibaldo R, Shapiro, Virginia S , Lee, Jeong-Heon , Schwab, Aaron D

Mayo Clinic

eLife | January 18, 2019 | Volume: 8 | Issue: No issue available | Pages: No page available

10.7554/elife.43821 | PMID 30657451 Get It

CD4 and CD8 T cells are vital components of the immune system. We found that histone deacetylase 3 (HDAC3) is critical for the development of CD4 T cells, as HDAC3-deficient DP thymocytes generate only CD8SP thymocytes in mice. In the absence of HDAC3, MHC Class II-restricted OT-II thymocytes are redirected to the CD8 cytotoxic lineage, which occurs with accelerated kinetics. Analysis of histone acetylation and RNA-seq reveals that HDAC3-deficient DP thymocytes are biased towards the CD8 lineage prior to positive selection. Commitment to the CD4 or CD8 lineage is determined by whether persistent TCR signaling or cytokine signaling predominates, respectively. Despite elevated IL-21R/γc/STAT5 signaling in HDAC3-deficient DP thymocytes, blocking IL-21R does not restore CD4 lineage commitment. Instead, HDAC3 binds directly to CD8-lineage promoting genes. Thus, HDAC3 is required to restrain CD8-lineage genes in DP thymocytes for the generation of CD4 T cells.